- Home
- MPAA vs NVCT Comparison
MPAA vs NVCT Comparison
Compare MPAA & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPAA
- NVCT
- Stock Information
- Founded
- MPAA 1968
- NVCT 2020
- Country
- MPAA United States
- NVCT United States
- Employees
- MPAA N/A
- NVCT N/A
- Industry
- MPAA Auto Parts:O.E.M.
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- MPAA Consumer Discretionary
- NVCT Health Care
- Exchange
- MPAA Nasdaq
- NVCT Nasdaq
- Market Cap
- MPAA 188.9M
- NVCT 184.9M
- IPO Year
- MPAA 1994
- NVCT 2022
- Fundamental
- Price
- MPAA $10.89
- NVCT $7.47
- Analyst Decision
- MPAA
- NVCT Strong Buy
- Analyst Count
- MPAA 0
- NVCT 3
- Target Price
- MPAA N/A
- NVCT $17.00
- AVG Volume (30 Days)
- MPAA 336.6K
- NVCT 188.7K
- Earning Date
- MPAA 06-09-2025
- NVCT 08-05-2025
- Dividend Yield
- MPAA N/A
- NVCT N/A
- EPS Growth
- MPAA N/A
- NVCT N/A
- EPS
- MPAA N/A
- NVCT N/A
- Revenue
- MPAA $757,354,000.00
- NVCT N/A
- Revenue This Year
- MPAA $7.74
- NVCT N/A
- Revenue Next Year
- MPAA $5.00
- NVCT N/A
- P/E Ratio
- MPAA N/A
- NVCT N/A
- Revenue Growth
- MPAA 5.53
- NVCT N/A
- 52 Week Low
- MPAA $5.16
- NVCT $4.44
- 52 Week High
- MPAA $12.72
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- MPAA 48.25
- NVCT 29.84
- Support Level
- MPAA $9.45
- NVCT $7.84
- Resistance Level
- MPAA $10.29
- NVCT $8.27
- Average True Range (ATR)
- MPAA 0.74
- NVCT 0.48
- MACD
- MPAA -0.11
- NVCT -0.09
- Stochastic Oscillator
- MPAA 27.52
- NVCT 5.18
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.